Latest Sigma-Aldrich Stories
ST. LOUIS, Dec. 11, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named to The Civic 50, a national ranking that recognizes the leading community-minded companies in the U.S. Based on a survey conducted by the National Conference on Citizenship (NCoC), a non-profit organization that champions civic leadership, and Points of Light, a non-partisan volunteer organization, The Civic 50 is the first scientific evaluation to rank companies using the criteria...
HANGZHOU, China, Nov. 28, 2012 /PRNewswire/ -- In recent years, along with continuous economic development and technological progress, the fine chemical industry has been in rapid development, with the speed obviously faster than that of the chemical industry as a whole. Up to now, fine chemical new materials and specialty chemicals have reached their average annual growth rate of 5 percent to 6 percent, 2 percent to 3 percent higher than that of the chemical industry. Besides, the...
RICHMOND, Calif., Nov. 27, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), announced today that it will host a live webcast of its upcoming Analyst and Investor Briefing which will be held in New York City at 5:00 pm ET on Thursday, December 6, 2012. During the briefing, members of Sangamo's management team will provide an update on the company's technology platform advancements and pipeline of ZFP Therapeutics(®) as well as near- and mid-term operating goals. The...
ST. LOUIS, Nov. 20, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced that Sigma Life Science, its innovative biological products and services business, today launched its CompoZr® Transporter Knockout human cell lines in a consumable, assay-ready plate format. The efflux transporter knockout cell lines allow precise identification of individual drug-transporter interactions, a critical component for understanding the safety and efficacy characteristics of...
ST. LOUIS, Nov. 19, 2012 /PRNewswire/ -- Effective January 1, 2013, Sigma-Aldrich Corporation (NASDAQ: SIAL) will align its organization into three market-focused business units that are defined by the customers and markets they serve. This new organization will enable Sigma-Aldrich to better address the needs of its global customers and to further drive global sales growth. Frank Wicks will transition from his current role as President of the Research business to become President...
ST. LOUIS, Nov. 16, 2012 /PRNewswire/ -- The Board of Directors of Sigma-Aldrich Corporation (NASDAQ: SIAL) has approved a quarterly cash dividend of $0.20 per share. The dividend is payable on December 14, 2012 to shareholders of record on November 30, 2012. About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical and organic chemical products, kits and services are used in scientific research, including genomic and proteomic...
ST. LOUIS, Nov. 13, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC(®) (www.safcglobal.com), has added more than 25 new raw materials to its portfolio of PharmaGrade products. Launched earlier this year, the PharmaGrade portfolio is comprised of over 65 high-quality buffers, amino acids and specialty chemicals, addressing the need for greater supply chain transparency and enhanced...
RICHMOND, Calif., Nov. 6, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic(® )development programs and an overview of the company's business strategy at 3:30 pm ET on Tuesday, November 13, 2012, at the Lazard Capital Markets 9th Annual Healthcare Conference which will be held in New York City. The presentation will be webcast live and...
ST. LOUIS, Oct. 30, 2012 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC(®) (www.safcglobal.com), has signed an agreement with Seoul, South Korea-based CrystalGenomics to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID). The agreement represents SAFC's premier pre-formulation services contract into the growing...
DALLAS, October 29, 2012 /PRNewswire/ -- The "Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) - Instruments, Reagents and Services - Trends and Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World. Browse 211 market data...
